photo caption: The inSight 3D wound management system from eKare provides a comprehensive solution for diagnosis, prognosis, and treatment of wounds, according to the company.
eKare has been selected after an open competition to join the Diabetic Foot Consortium (DFC) organized by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a branch of the National Institute of Health (NIH).
The objective of the DFC is to establish an organizational framework at the national level to facilitate integrated clinical and translational research to improve outcomes for patients with diabetic foot ulcers (DFUs), according to a media release from eKare.
The DFC is prioritizing DFU research and accelerating the development and validation of wound biomarkers to improve prediction of outcomes. The consortium includes:
- Indiana University
- Stanford University
- University of California – San Francisco
- University of Miami
- University of Michigan
- University of Pittsburgh
eKare’s inSight, a comprehensive 3D wound management system, will be uniformly utilized across the institutions for standardized data collection and monitoring of wound progression, the company notes.
“An initiative of such breadth and rigor dedicated to diabetic foot ulcer research is unprecedented,” says Patrick Cheng, CEO of eKare, in the release. “eKare is honored to have been selected by NIDDK and join the Diabetic Foot Consortium to help spearhead breakthrough advancements in DFU research.”
[Source(s): eKare Inc, PRWeb]